动脉静脉囊功能障碍中的病理机制和治疗分子标
Ruiwei Yan1, Anni Song1, Chun Zhang1
1Department of Nephrology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
International journal of molecular sciences
|September 14, 2024
概括
在血液透析患者中,动脉静脉 (AVF) 衰竭是常见的,原因是外向和内向血管重塑. 了解这些机制是改善AVF功能和患者结果的关键.
科学领域:
- 血管外科 血管外科
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物医学工程 生物医学工程
背景情况:
- 需要血液透析的末期病 (ESRD) 患者在全球范围内正在增加.
- 动脉静脉 (AVF) 是血液透析的首选血管接入 (VA),但患有高初级成熟失败率 (高达60%).
- AVF功能障碍显著影响患者的预后.
研究的目的:
- 审查诊断,监测和治疗AVF功能障碍的临床策略.
- 探索AVF功能障碍中外向和内向血管重塑的病理机制.
- 确定缓解AVF功能障碍的潜在治疗点.
主要方法:
- 对AVF功能障碍的当前临床诊断,监测和治疗技术的审查.
- 讨论 AVF 外向和内向重塑背后的病理机制.
- 外向和内向重塑之间的分子机制的比较分析.
主要成果:
- AVF功能障碍与外向重塑 (血管壁加厚,膜扩张) 和内向重塑 (内极性增多) 有关.
- 这两种改造类型是相互关联的,在决定AVF命运时至关重要.
- 分析了外向和内向重塑的分子机制的相似性和差异.
结论:
- 研究外向和内向重塑的机制对于开发改善AVF功能的策略至关重要.
- 识别关键的分子标可以帮助缓解AVF功能障碍并改善血液透析患者的治疗结果.
- 本综述总结了对AVF功能障碍具有潜在临床价值的治疗点.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:24Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
01:16Clot Retraction and Fibrinolysis
4.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
4.9K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
398
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
398
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
652
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
652
01:10Mechanism of Angiogenesis
5.3K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.3K